Home>
US Stocks>
Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. share price today

(INBX)

Inhibrx Biosciences, Inc. share price is $15.7 & ₹1,328.90 as on 7 Dec 2024, 2.30 'hrs' IST

$15.7

▲

0.6

(3.97%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Inhibrx Biosciences, Inc. share price in Dollar and Rupees. Guide to invest in Inhibrx Biosciences, Inc. from India. Also see the sentimental analysis on Indian investors investing in Inhibrx Biosciences, Inc. . Get details on the Indian mutual funds that are investing in Inhibrx Biosciences, Inc. . Get Analyst recommendations and forecasts along with all the Inhibrx Biosciences, Inc. 's financials.

Inhibrx Biosciences, Inc. share price movements

$15.14
$15.99
$15.70
3.57%
Downside
Day's Volatility :5.32%
Upside
1.81%
$10.80
$39.79
$15.70
31.21%
Downside
52 Weeks Volatility :72.86%
Upside
60.54%

Inhibrx Biosciences, Inc. Returns

Period	Inhibrx Biosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.66%	-5.7%	0.0%
6 Months	-8.98%	-0.8%	0.0%
1 Year	-39.53%	9.9%	0.0%
3 Years	-63.81%	10.7%	-19.7%

Inhibrx Biosciences, Inc. Key Statistics

in dollars & INR

Previous Close	$15.1
Open	$15.26
Today's High	$15.99
Today's Low	$15.14
Market Capitalization	$218.6M
Today's Volume	$81.6K
52 Week High	$39.79
52 Week Low	$10.8
Revenue TTM	$1.7M
EBITDA	$-300.9M
Earnings Per Share (EPS)	$119.39
PE Ratio	0.13
Profit Margin	101974.22%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-2031.05%

How to invest in Inhibrx Biosciences, Inc. from India?

It is very easy for Indian residents to invest directly in Inhibrx Biosciences, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inhibrx Biosciences, Inc. stock in both rupees (INR) and dollars (USD). Search for Inhibrx Biosciences, Inc. or INBX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inhibrx Biosciences, Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inhibrx Biosciences, Inc. shares which would translate to 0.054 fractional shares of Inhibrx Biosciences, Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Inhibrx Biosciences, Inc.

-58%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Inhibrx Biosciences, Inc. on INDmoney from India has reduced in the last 30 days as on Dec 7, 2024. -58% less investors are searching Inhibrx Biosciences, Inc. in the last 30 days versus the previous period.

Global Institutional Holdings in Inhibrx Biosciences, Inc.

DekaBank Deutsche Girozentrale
0.05%
Advisor Group Holdings, Inc.
0.01%

Analyst Recommendation on Inhibrx Biosciences, Inc.

Hold

0%Buy

62%Hold

37%Sell

Based on 8 Wall street analysts offering stock ratings for Inhibrx Biosciences, Inc. (by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Inhibrx Biosciences, Inc.

What analysts predicted

Downside of 4.46%

Current:

$15.70

Target:

$15.00

Insights on Inhibrx Biosciences, Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 1.63M → 100.0K (in $), with an average decrease of 93.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.85B → -43.86M (in $), with an average decrease of 102.4% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 84.8%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 101.0%

Inhibrx Biosciences, Inc. Technicals Summary

Sell

Neutral

Buy

Inhibrx Biosciences, Inc. is currently in a neutral trading position according to technical analysis indicators.

Inhibrx Biosciences, Inc. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inhibrx Biosciences, Inc.	-5.92%	-8.98%	-39.53%	-63.81%	-26.81%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	11.44%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inhibrx Biosciences, Inc.	0.13	0.13	NA	102.04	-20.31	-0.57	NA	15.15
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inhibrx Biosciences, Inc.	Hold	$218.6M	-26.81%	0.13	101974.22%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Inhibrx Biosciences, Inc.

Organization	Inhibrx Biosciences, Inc.
Employees	166
CEO	Mr. Mark Paul Lappe
Industry	Health Technology

Management People of Inhibrx Biosciences, Inc.

Name	Title
Mr. Mark Paul Lappe	CEO, President & Chairman
Ms. Kelly Devine Deck B.S., CPA, M.S.	Executive VP, CFO & Treasurer
Ms. Bonne Adams M.B.A.	Vice President of Operations
Dr. Ashraf Amanullah Ph.D.	Executive VP, Chief Technical Operations Officer
Dr. Brendan P. Eckelman Ph.D.	Executive VP & Chief Scientific Officer
Ms. Leah Pollema J.D.	VP & General Counsel
Dr. Charbel Helaihel Pharm.D.	Vice President of Marketing & Commercial Planning
Mr. Jeffrey J. Jensen	Executive VP & Chief Clinical Operations Officer
Dr. Josep Garcia Ph.D.	Executive VP & Chief Clinical Development Officer
Mr. David Matly M.B.A.	Executive VP and Chief Commercial & Business Development Officer

Important FAQs about investing in Inhibrx Biosciences, Inc. from India :

What is Inhibrx Biosciences, Inc. share price today?

Inhibrx Biosciences, Inc. (INBX) share price today is $15.70.

Can Indians buy Inhibrx Biosciences, Inc. shares?

Yes, Indians can invest in the Inhibrx Biosciences, Inc. (INBX) from India.

With INDmoney, you can buy Inhibrx Biosciences, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inhibrx Biosciences, Inc. at zero transaction cost.

How can I buy Inhibrx Biosciences, Inc. shares from India?

It is very easy to buy Inhibrx Biosciences, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inhibrx Biosciences, Inc. be purchased?

Yes, you can buy fractional shares of Inhibrx Biosciences, Inc. with INDmoney app.

What are the documents required to start investing in Inhibrx Biosciences, Inc. stocks?

To start investing in Inhibrx Biosciences, Inc. , You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.